OSE Immunotherapeutics SA
OSE · EURONEXT · EUR
€2.16
−0.098 −4.34%todayNot financial advice.
- Open
- 2.26
- Day range
- 2.16 - 2.26
- 52-week range
- 2.01 - 6.48
- Volume
- 172.1K
- Market cap
- 57.11M
- P/E ratio
- —
- EPS
- —
- Dividend yield
- 0.00%
- Beta
- 0.56
Performance
W
+1.89%
1M
−18.80%
3M
−32.50%
6M
−34.27%
YTD
−58.58%
Y
−64.00%
5Y
−78.82%
All
−80.18%
In the news
Oct 19
OSE Immunotherapeutics Phase 2 Trial Meets Main Goal in Lung Cancer Study
OSE Immunotherapeutics met its primary goal in a Phase 2 lung cancer study, showing improved one-year survival rates for its Tedopi combinations.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/EURONEXT-OSE" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="OSE Immunotherapeutics SA (OSE) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/EURONEXT-OSE">OSE stock price</a> by FreeTheAI Stocks</p>